Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
Primary brain tumours in adults
The most frequent adult-type primary CNS tumours are diffuse gliomas, but a large variety of
rarer CNS tumour types exists. The classification of these tumours is increasingly based on …
rarer CNS tumour types exists. The classification of these tumours is increasingly based on …
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version …
These joint practice guidelines, or procedure standards, were developed collaboratively by
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …
Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma
M Harat, J Rakowska, M Harat, T Szylberg… - Nature …, 2023 - nature.com
Accurate determination of the extent and grade of adult-type diffuse gliomas is critical to
patient management. In clinical practice, contrast-enhancing areas of diffuse gliomas in …
patient management. In clinical practice, contrast-enhancing areas of diffuse gliomas in …
Advances in neuro-oncology imaging
Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …
monitoring of patients with brain tumours, conventional MRI sequences have two key …
Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives
W Szopa, TA Burley, G Kramer-Marek… - BioMed research …, 2017 - Wiley Online Library
Glioblastoma (GBM) is a primary neuroepithelial tumor of the central nervous system,
characterized by an extremely aggressive clinical phenotype. Patients with GBM have a …
characterized by an extremely aggressive clinical phenotype. Patients with GBM have a …
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
MJ van den Bent, JS Wefel, D Schiff… - The lancet …, 2011 - thelancet.com
Although low-grade gliomas (LGG) have a less aggressive course than do high-grade
gliomas, the outcome of these tumours is ultimately fatal in most patients. Both the tumour …
gliomas, the outcome of these tumours is ultimately fatal in most patients. Both the tumour …
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group
N Galldiks, M Niyazi, AL Grosu, M Kocher… - Neuro …, 2021 - academic.oup.com
The management of patients with glioma usually requires multimodality treatment including
surgery, radiotherapy, and systemic therapy. Accurate neuroimaging plays a central role for …
surgery, radiotherapy, and systemic therapy. Accurate neuroimaging plays a central role for …
[PDF][PDF] Modern brain tumor imaging
The imaging and clinical management of patients with brain tumor continue to evolve over
time and now heavily rely on physiologic imaging in addition to high-resolution structural …
time and now heavily rely on physiologic imaging in addition to high-resolution structural …
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy
W Chen, DHS Silverman, S Delaloye… - Journal of Nuclear …, 2006 - Soc Nuclear Med
We evaluated the amino acid and glucose metabolism of brain tumors by using PET with 3,
4-dihydroxy-6-18F-fluoro-l-phenylalanine (18F-FDOPA) and 18F-FDG. Methods: Eighty-one …
4-dihydroxy-6-18F-fluoro-l-phenylalanine (18F-FDOPA) and 18F-FDG. Methods: Eighty-one …